Pfizer wins first U.S. trial over Zoloft birth-defect risk

(Reuters) - Pfizer Inc scored a key victory Friday when it was cleared of liability in the first U.S. trial involving claims that its antidepressant Zoloft can cause birth defects in children born to women who take the drug while pregnant.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news